TITLE

Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis

PUB. DATE
January 2008
SOURCE
BMC Genetics;2008, Vol. 9, p351
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
43750472

 

Related Articles

  • New Radiation Technology Targets Tumors.  // South Dakota Medicine;Sep2014, Vol. 67 Issue 9, p362 

    The article previews the Elekta Versa HD linear accelerator for stereotactic radiosurgery and stereotactic body radiation therapy.

  • New Lung Cancer Therapy Found Effective.  // AARC Times;Jun2010, Vol. 34 Issue 6, p74 

    The article presents a study which shows that a noninvasive procedure named stereotactic body radiation therapy (SBRT) was efficient in removing the recurrence of primary lung cancer in 98% of 5 patients determined with early-stage non-small-cell lung cancer.

  • Renal cell carcinoma treated with stereotactic radiotherapy with histological change confirmed on autopsy: a case report. Hiroshi Onishi; Tomonori Kawasaki; Hidenori Zakoji; Takashi Yoshida; Takafumi Komiyama; Kengo Kuriyama; Masayuki Araya; Ryo Saito; Shinichi Aoki; Yoshiyasu Maehata; Licht Tominaga; Kan Marino; Iori Watanabe; Mitsuhiko Oguri; Tsutomu Araki; Nobuyuki Enomoto; Masayuki Takeda; Ryohei Katoh // BMC Research Notes;2014, Vol. 7 Issue 1, p3 

    Background Treatment of primary renal cell carcinoma using radiotherapy with curative intent is rare, because renal cell carcinoma is generally regarded as a radiation-resistant tumor. Recently, stereotactic body radiation therapy has been radically applied for cancers in various organs...

  • Lung Cancer, Other Minimally Invasive Radiation Therapy Treatments Focus of International Radiation Oncology Conference.  // Ascribe Newswire: Medicine;5/19/2004, p168 

    As leaders in the advancement of stereotactic body radiation therapy, Indiana University School of Medicine Department of Radiation Oncology will host an international conference for physicians and researchers. The third annual Conference on Stereotactic Body Radiation Therapy will be held on...

  • Stereotactic body radiotherapy for second pulmonary nodules after operation for an initial lung cancer. Kinji Nishiyama; Ken Kodama; Teruki Teshima; Hirohito Tada // Japanese Journal of Clinical Oncology;Oct2015, Vol. 45 Issue 10, p947 

    Objective: A second lung cancer is occasionally observed in patients who underwent surgical resection of the index lung cancer. The purpose of this study is to evaluate stereotactic body radiation therapy for second lung cancer. Methods: Fifty-one medically inoperable patients who underwent...

  • One-Week Course Offers Option for Prostate Treatment.  // Radiology Today;Dec2012, Vol. 13 Issue 12, p28 

    The article discusses a research report which showed that higher doses of stereotactic radiotherapy with fewer fractions delivered promising results in terms of tumor control in patients with organ-confined prostate cancer. The results also showed that stereotactic body radiation therapy (SBRT)...

  • Higher Radiation Doses, Fewer Treatments.  // USA Today Magazine;Oct2011, Vol. 140 Issue 2797, p14 

    The article focuses on the results of a multicenter clinical trial which showed the efficacy and safety of higher doses of stereotactic body radiation therapy (SBRT) that involves fewer treatments to patients with low- to intermediate-risk prostate cancer.

  • Busulfan.  // Reactions Weekly;Mar2015, Vol. 1541 Issue 1, p64 

    An abstract of the article "Stereotactic body radiation therapy for lung metastases in a child with ewing sarcoma," by M. Amsbaugh and colleagues is presented.

  • Regorafenib.  // Reactions Weekly;Nov2014, Vol. 1529 Issue 1, p172 

    An abstract of the article "Regorafenib-induced transverse myelopathy after stereotactic body radiation therapy," by S. Tian and colleagues is presented.

  • Stereotactic body radiation therapy for primary lung cancers clinically diagnosed without pathological confirmation: a single-institution experience. Yoshitake, Tadamasa; Nakamura, Katsumasa; Shioyama, Yoshiyuki; Sasaki, Tomonari; Ohga, Saiji; Shinoto, Makoto; Terashima, Kotaro; Asai, Kaori; Matsumoto, Keiji; Matsuo, Yoshio; Baba, Shingo; Honda, Hiroshi // International Journal of Clinical Oncology;Feb2015, Vol. 20 Issue 1, p53 

    Background: Pathological diagnosis of small lung lesions is sometimes difficult in medically inoperable patients. The purpose of this study was to evaluate the adverse events and the outcomes of stereotactic body radiation therapy (SBRT) for lung lesions which were clinically diagnosed as...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics